States, France, Germany, and the United Kingdom between 1999 and 2007. Gay et al. (2011) compared amenable mortality rates in 31 OECD countries from 1997 to 2007 and found a declining trend in amenable mortality rates in every examined time period.
The aim of our study was to update the amenable mortality rates in 32 OECD countries at 2013 or the last available year, to describe the annual variations in mortality amenable to health care during [2000] [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] , to determine whether these changes were constant over time, and to evaluate the pattern across geographic areas.
METHODS
A time trend analysis was performed using secondary data from 32 OECD countries during the period 2000 to 2013. These countries were chosen based on the availability of data and to allow for comparison with the study by Gay et al. (2011) .
The mortality and population data for this study came primarily from the World Health Organization (WHO) Mortality Database (World Health Organization [WHO] 2014), in which causes of death are coded according to the ICD-9 or ICD-10. If reference populations were not available in the WHO Mortality Database, the data were extracted from the 2012 Revision of the World Population Prospects (United Nations [UN] 2014). The countries included in the study are listed in Appendix S1. Nolte and McKee (2003 , 2004 , 2008 and Tobias and Yeh (2009) prepared two different lists of causes of death amenable to health care. These two lists were used by the OECD to generate estimates of amenable mortality for 31 countries (Gay et al. 2011) . After reviewing the two sets of estimates of amenable mortality for the OECD countries provided by Nolte and McKee's and Tobias and Yeh's lists, we decided to use Nolte and McKee's because it provides, on average, more conservative figures. Nolte and McKee's list of causes of death amenable to health care is in Appendix S2.
For each country, age-standardized amenable mortality rates (amenable SDRs) were calculated as the annual number of deaths in the population aged 0-74 years per 100,000 inhabitants, with direct standardization to the 2010 OECD population. SDRs were stratified by geographic area (Northern Europe, Central Europe, Atlantic Europe, Southern Europe, Eastern Europe, North America, Latin America, Middle East, East Asia, and Oceania) (Rossi et al. 2015; World Bank 2015) and three disease categories-the two leading causes of death amenable to health care in OECD countries during the examined years (cancers and cardiovascular diseases) and all of the remaining causes (see Appendix S2).
First, the data were summarized by presenting the average annual amenable SDRs for the years 2000/2003 and 2010/2013 and by computing the percentage change in amenable SDRs between these time periods. Second, we performed a mixed-effects polynomial regression analysis on the annual amenable SDRs, with random intercepts and slopes for each country. In this model, we included geographic area and its interaction with year to determine whether specific geographic areas were associated with different amenable SDR trajectories over time. We chose to fit a polynomial model to investigate the presence of nonlinear trajectories of amenable SDRs, that is, to determine whether the annual changes in amenable SDRs were constant over time. Finally, we estimated confidence intervals for all linear and quadratic slope parameters to test whether they were smaller, larger, or indistinguishable (i.e., neither smaller nor larger) compared with the average value across all OECD countries.
For all analyses, the significance level was set at p < .05. All data were analyzed using the Stata software package, version 13 (StataCorp. 2013, Stata Statistical Software: Release 13; StataCorp LP, College Station, TX, USA).
RESULTS

Amenable SDRs
Figure 1 displays the amenable SDRs from all causes per 100,000 persons aged 0-74, in all 32 countries, stratified by geographic area. All countries experienced decreases in amenable mortality between 2000 and 2013, with differences among geographic regions. Countries in Atlantic Europe, North America, and Oceania showed homogeneous declines, whereas Latin America, East Asia, and Eastern Europe exhibited large within-region differences in the reduction of amenable mortality. Diseases of the cardiovascular system and cancers were the two leading causes of amenable mortality and accounted for 48.4 and 25.8 percent, respectively, of overall amenable mortality in OECD countries during the 14-year period. n/a n/a n/a n/a n/a n/a n/a n/a in Latin America. The percentage change was approximately 20-30 percent in all of the other regions. The lowest percentage change was found in Mexico (À5.7 percent), whereas the highest change occurred in South Korea (À47.5 percent). Additionally, the percentage decrease in the cardiovascular disease SDR was higher than the percentage change in the all-cause SDR in all countries. In contrast, the percentage change in the SDR from cancer was always lower than the corresponding change in the all-cause SDR, with the sole exception of Mexico.
Annual Trends in Amenable SDRs
OECD Countries. The OECD average annual decrease in amenable mortality was 3.6 per 100,000 (coefficient for the linear term = À3.6; 95 percent CI = À4.2, À2.9), but this decrease slowed over time (coefficient for the quadratic term = 0.11; 95 percent CI = 0.08, 0.14) (Figure 2 ). The mixed-effects regression model showed that there was a significant difference among the country-specific slopes (standard deviation [SD] = 1.8, p < .001). Countries All OECD countries experienced a slowdown in the reduction of amenable SDRs during the 14-year period, with the exception of Denmark (coefficient for the quadratic term = 0.00; 95 percent CI = À0.07, 0.08), Iceland (0.08; 95 percent CI = À0.02, 0.18), Belgium (0.07; 95 percent CI = À0.01, 0.14), France (0.08; 95 percent CI = À0.01, 0.16), Spain (0.05; 95 percent CI = À0.02, 0.11), Poland (0.06; 95 percent CI = À0.00, 0.13), Canada (0.08; 95 percent CI = À0.01, 0.18), the United States (0.07; 95 percent CI = À0.02, 0.17), and Japan (0.06; 95 percent CI = À0.01, 0.12).
Geographic Area. Eastern and Atlantic European countries had among the highest age-standardized amenable mortality rates in 2000 and steeper declines (À6.1 and À4.7, respectively) than did other geographic areas: Northern Europe À3.2, Central Europe À2.9, Southern Europe À2.8, North America À2.4, Middle East À3.0, East Asia À3.8, Oceania À3.0, and Latin America À1.7 (Figure 2) . Compared with the OECD average, the average annual decrease was larger in the Atlantic and Eastern Europe; smaller in Central Europe, North America, Latin America, Middle East, and Oceania; and neither smaller nor larger in Northern Europe, Southern Europe, and East Asia (Table 2) . Focusing on specific causes of amenable mortality, we found a significant association between geographic area and the reduction of amenable mortality from cardiovascular diseases, but not from cancers and other amenable conditions. Diseases. Table 2 shows that the OECD average annual decline in amenable mortality during the 14-year period was À0.5 (95 percent CI = À0.6, À0.4) for cancers and À2.5 (95 percent CI = À3.0, À2.0) for diseases of the cardiovascular system, with significant differences among OECD countries (cancers: Note.
For the sake of brevity, we report only the coefficients for the linear term in the regression model. *Neither smaller nor larger means that the 95% confidence interval (CI) for that country's slope parameter overlaps the average value across all countries, whereas smaller and larger mean that the confidence interval does not overlap the average value, that is, the slope parameter is significantly smaller or larger than the average. †
The 95% CI crosses 0, indicating nonsignificant slope.
1920 HSR: Health Services Research 52:5 (October 2017) SD = 0.3, p < .001; cardiovascular diseases: SD = 1.4, p < .001). The declining trend in cancer-amenable SDRs was linear (coefficient of the quadratic term = 0.01; 95 percent CI = À0.00, 0.02; p = .07), whereas the decrease in cardiovascular disease SDRs slowed over time (0.10; 95 percent CI = 0.07, 0.12; p < .001), with significant differences among countries (SD = 0.05, p < .001). The average annual decrease compared with the OECD average for cardiovascular diseases was larger in all Atlantic and Eastern Europe; smaller in Northern and Central Europe, Northern and Latin America, Middle East, and Oceania; and neither smaller nor larger in Southern Europe and East Asia. For cancers, the average annual decrease compared with the OECD average was larger in Atlantic Europe, Middle East, and Oceania, and smaller in Southern Europe, Latin America, and East Asia. Eastern and Atlantic European countries, which had declining slopes greater than the OECD average, had higher cardiovascular disease SDRs in 2000, whereas countries with relatively slow declines (range between À1.1 and À1.8) had low cardiovascular mortality rates in 2000. Similarly, the countries with slopes greater than the OECD average were those with higher cancer-amenable SDR in 2000 (≥30 per 100,000); the only exception was the United States, which started with a relatively low cancer-amenable SDR of 27 per 100,000 in 2000 and had a slope of À0.6. The only countries where some of the disease-specific mortality reductions were not statistically significant were Mexico (cardiovascular diseases), Greece (cancers), and Luxembourg, Slovakia, and Canada (other causes).
All OECD countries experienced a slowdown in the reduction of cardiovascular disease SDRs during the 14-year period, with the exception of Denmark (coefficient for the quadratic term = 0.04; 95 percent CI = À0.02, 0.09), Belgium (0.05; 95 percent CI = À0.00, 0.11), France (0.06; 95 percent CI = À0.01, 0.12), Spain (0.03; 95 percent CI = À0.02, 0.08), United States (0.06; 95 percent CI = À0.01, 0.13), Chile (0.07; 95 percent CI = À0.00, 0.14), and Japan (0.03; 95 percent CI = À0.02, 0.08). The countries where this slowdown was more pronounced were Ireland (0.21; 95 percent CI = 0.14, 0.28), Czech Republic (0.20; 95 percent CI = 0.15, 0.25), and Austria (0.19; 95 percent CI = 0.14, 0.23).
DISCUSSION
The aim of our study was to update the amenable mortality rates at 2013 (or last available year) in 32 OECD countries, to describe the annual variations in Declining Amenable Mortalitymortality amenable to health care during 2000-2013, to determine whether these changes were constant over time, and to evaluate their association with various geographic areas. Our results showed a clear decline in amenable SDRs in all 32 OECD countries between 2000 and 2010/2013. This result confirms that previously documented trends are continuing to 2010/2013 (Charlton and Velez 1986; Boys, Forster, and J ozan 1991; Kjellstrand, Kovithavongs, and Szabo 1998; Nolte and McKee 2008) .
Inferential statistical analysis provided information on the scale of decline by showing the annual change in amenable SDRs. All 32 OECD countries experienced a significant decline in amenable mortality rates for all causes with an average annual rate of change of À3.6 percent. This finding is in agreement with that of Gay et al. (2011) , who measured the average annual change in amenable mortality in 31 OECD countries between 1997 and 2007 and concluded that amenable mortality declined in all OECD countries, with an average annual decline of 3.7 percent. Although amenable SDRs have fallen in all geographic areas between 2000 and 2013, the scale of improvement has varied substantially across geographic areas: Latin America experienced the slowest decline and Eastern Europe and Atlantic Europe the most rapid decline between 2000 and 2010/2013. As a result, amenable mortality rates in Latin America were high in 2010/2013, in comparison with the average rate of all areas. One of the reasons for the low slope, supported by previous studies (Arah et al. 2005; Nolte and McKee 2011) , may be the lack of universal health care coverage. In Mexico and Chile, coverage has grown in recent years, but it was not until 2011 that nearly 90 percent of the population was covered (Organisation for Economic Co-operation and Development [OECD] 2011 [OECD] , 2013a .
In 2013, the amenable SDR in Eastern Europe, as Velkova, Wolleswinkel-van den Bosch, and Mackenbach (1997) previously demonstrated, was still relatively high compared with other areas. Nevertheless, large gains were seen in comparison with geographic areas where the amenable SDR was lower: in 2000, the gap was 94 deaths for 100,000 (compared with Southern Europe and Oceania areas), whereas in 2013 it was 76 (compared with Oceania). The high slope in Eastern Europe, and especially in Estonia, may have been facilitated by the rapid implementation of innovations and advances in treatment. Mackenbach et al. (2013) showed that amenable mortality rates in Estonia started to drop from 2000 because Estonia was able to adopt many new interventions only after independence in 1991. In a European project (Amenable mortality in the European Union: toward better indicators for the effectiveness of health systems [AMIEHS] 2011), the impact of new interventions that are likely to contribute to reduce mortality from amenable causes of death was analyzed in seven European countries (UK, The Netherlands, Germany, France, Spain, Sweden, Estonia). These interventions included treatments for cardiovascular disease and cancer, and cancer screening. This project showed that the introduction of innovations occurred later in Estonia (1990s and 2000s) than in the other countries (1980s and early 1990s) . Additionally, screening programs started in the 2000s in certain Eastern European countries (OECD 2013b) with delays in comparison to other Eastern European countries. These delays in implementing guidelines and protocols may have contributed to the high slope in Eastern Europe. B€ ohm et al. (2013) concluded that the health systems of Eastern European countries are related by their common history, sharing a Semashko system during the Soviet era. Treatment guidelines were not part of the medical culture during this time, but they have been adopted more recently.
By 2013, amenable mortality rates in Atlantic Europe grew closer to levels of the other areas (except Latin America and Eastern Europe) that were lower in 2000. These results appear to reflect improvements in uptake of medical and surgical treatments of cardiovascular diseases, as well as changes in risk factors such as smoking. This interpretation is consistent with Bajekal et al. (2012) , who found that medical and surgical treatments were responsible for approximately half of the decline in deaths from coronary heart disease (a subgroup of cardiovascular diseases) between 2000 and 2007 in England.
Our results also suggest that amenable SDRs are reaching a level of stability in most advanced countries. Only Denmark, Iceland, Belgium, France, Spain, Poland, Canada, and Japan did not demonstrate a decreasing slope of amenable mortality over time. This finding suggests that the health care systems of the most advanced countries may find it increasingly difficult to achieve additional gains (Nolte and McKee 2012) . This interpretation gains some support from a study of the annual decline in amenable mortality for four conditions in seven European countries (Mackenbach et al. 2013) .
Our study has its strengths and weaknesses. We updated the absolute levels of mortality from amenable conditions, but we also estimated the rate of mortality decline. This second measure may be a better indicator of the performance of national health systems, because the rate of decline is less likely to be biased by such confounding factors as baseline health risks and exposures.
Our analysis was conducted at the country level only and did not disaggregate mortality by ethnicity, race, or socioeconomic characteristics; thus, potentially large variations within populations may be concealed. Evidence from New Zealand, Australia, and Europe points to higher levels of amenable mortality in indigenous and immigrant populations compared with nonindigenous and native-born populations (Westerling and Ros en 2002; Page, Tobias, and Glover 2006; Stirbu et al. 2006) . Studies from the United States and Europe also observed higher levels of amenable mortality among people disadvantaged in terms of race or socioeconomic status (Schwartz et al. 1990; Westerling, Gullberg, and Ros en 1996; Macinko and Elo 2009) .
In addition, our analysis did not disaggregate amenable mortality by individual causes, thereby potentially concealing variations among countries. In previous studies, the starting levels and trends of individual causes of death varied greatly across 17 European countries and 6 other countries, which were selected to provide a variety of forms of health care delivery (Charlton and Velez 1986; Treurniet, Boshuizen, and Harteloh 2004) .
In conclusion, our study revealed the following: (1) the declining trend of amenable mortality rates continued to 2013 (or last available year); (2) amenable SDRs declined during 2000-2013 in all of the geographic areas and countries, but at different rates; and (3) there was a slowdown in the amenable mortality rate reduction. If amenable mortality is defined as "premature death that should not occur in the presence of timely and effective health care," then our results should prompt further studies to monitor trends over time and investigate the specific causes that drive the slowing of the decrease in amenable deaths in most national health systems.
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